Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).

Efficace F, Buckstein R, Abel GA, Giesinger JM, Fenaux P, Bewersdorf JP, Brunner AM, Bejar R, Borate U, DeZern AE, Greenberg P, Roboz GJ, Savona MR, Sparano F, Boultwood J, Komrokji R, Sallman DA, Xie Z, Sanz G, Carraway HE, Taylor J, Nimer SD, Della Porta MG, Santini V, Stahl M, Platzbecker U, Sekeres MA, Zeidan AM

Open source

DOI: 10.1002/hem3.69
Published: 2024 May
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/hem3.69,
  title = {Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).},
  author = {Efficace F and Buckstein R and Abel GA and Giesinger JM and Fenaux P and Bewersdorf JP and Brunner AM and Bejar R and Borate U and DeZern AE and Greenberg P and Roboz GJ and Savona MR and Sparano F and Boultwood J and Komrokji R and Sallman DA and Xie Z and Sanz G and Carraway HE and Taylor J and Nimer SD and Della Porta MG and Santini V and Stahl M and Platzbecker U and Sekeres MA and Zeidan AM},
  year = {2024},
  journal = {HemaSphere},
  doi = {10.1002/hem3.69},
  url = {https://doi.org/10.1002/hem3.69}
}

RIS

TY  - JOUR
TI  - Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).
AU  - Efficace F
AU  - Buckstein R
AU  - Abel GA
AU  - Giesinger JM
AU  - Fenaux P
AU  - Bewersdorf JP
AU  - Brunner AM
AU  - Bejar R
AU  - Borate U
AU  - DeZern AE
AU  - Greenberg P
AU  - Roboz GJ
AU  - Savona MR
AU  - Sparano F
AU  - Boultwood J
AU  - Komrokji R
AU  - Sallman DA
AU  - Xie Z
AU  - Sanz G
AU  - Carraway HE
AU  - Taylor J
AU  - Nimer SD
AU  - Della Porta MG
AU  - Santini V
AU  - Stahl M
AU  - Platzbecker U
AU  - Sekeres MA
AU  - Zeidan AM
PY  - 2024
JO  - HemaSphere
DO  - 10.1002/hem3.69
UR  - https://doi.org/10.1002/hem3.69
ER  -

APA

F, E., R, B., GA, A., JM, G., P, F., JP, B., AM, B., R, B., U, B., AE, D., P, G., GJ, R., MR, S., F, S., J, B., R, K., DA, S., Z, X., G, S., HE, C., J, T., SD, N., MG, D. P., V, S., M, S., U, P., MA, S., & AM, Z. (2024). Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).. HemaSphere. https://doi.org/10.1002/hem3.69

Source records

pubmed · retrieved 2026-09-26T19:49:50.240Z